Paxman AB

PAX · Nasdaq Stockholm · Healthcare

66.20SEK +1.1%last day

Price as of 2 October 2026

The price over the past year, with dividends: −9.3%

Performance

1 month

+14.3%

1 year

−9.3%

3 years, per year

+25.5%

5 years, per year

+5.3%

Largest fall, 3 years

−65.9%

Below the peak now

−21.0%

Volatility, 1 year

40.9%

Return with dividends reinvested.

Key figures

P/E

negative earnings

P/B

3.6

Dividend yield

0.0%

Return on equity

−1.2%

Net margin

−1.4%

Market value

155 m USD

Quality, value and trend

Where Paxman stands against every Nordic stock today. 100 is best.

Quality50

Profitability and a sound balance sheet over time. Better than 50% of Nordic stocks.

Value19

The price measured against earnings, assets and cash flow. Better than 19% of Nordic stocks.

Trend77

The price development over the past year. Better than 77% of Nordic stocks.

Combined44

Quality, value and trend together. Better than 44% of Nordic stocks.

About Paxman

Paxman AB is a company in healthcare, listed on Nasdaq Stockholm. The share trades in SEK. It has around 150 employees.

Paxman AB (publ), together with its subsidiaries, provides cryotherapy solutions in the United Kingdom, Europe, North and South America, Oceania, and Asia. The company offers Paxman scalp cooling system, a mechanized form of scalp cooling for the prevention of chemotherapy-induced alopecia. It also engages in the development of a medical cryocompression device for the prevention of chemotherapy-induced peripheral neuropathy. The company was founded in 1996 and is based in Karlshamn, Sweden.

See the full analysis in InvestWiser.

The accounts, dividends, 40 years of charts and the comparison with other stocks are in the app.

See the full analysis